- Home
- ETON vs AMBC Comparison
ETON vs AMBC Comparison
Compare ETON & AMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- AMBC
- Stock Information
- Founded
- ETON 2017
- AMBC 1971
- Country
- ETON United States
- AMBC United States
- Employees
- ETON N/A
- AMBC N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- AMBC Property-Casualty Insurers
- Sector
- ETON Health Care
- AMBC Finance
- Exchange
- ETON Nasdaq
- AMBC Nasdaq
- Market Cap
- ETON 388.3M
- AMBC 411.3M
- IPO Year
- ETON 2018
- AMBC 1991
- Fundamental
- Price
- ETON $14.39
- AMBC $8.28
- Analyst Decision
- ETON Strong Buy
- AMBC Strong Buy
- Analyst Count
- ETON 3
- AMBC 2
- Target Price
- ETON $29.67
- AMBC $12.50
- AVG Volume (30 Days)
- ETON 420.1K
- AMBC 994.5K
- Earning Date
- ETON 08-07-2025
- AMBC 08-07-2025
- Dividend Yield
- ETON N/A
- AMBC N/A
- EPS Growth
- ETON N/A
- AMBC N/A
- EPS
- ETON N/A
- AMBC N/A
- Revenue
- ETON $48,327,000.00
- AMBC $253,912,000.00
- Revenue This Year
- ETON $101.12
- AMBC N/A
- Revenue Next Year
- ETON $45.71
- AMBC $18.20
- P/E Ratio
- ETON N/A
- AMBC N/A
- Revenue Growth
- ETON 40.88
- AMBC 125.08
- 52 Week Low
- ETON $3.25
- AMBC $5.99
- 52 Week High
- ETON $21.48
- AMBC $13.64
- Technical
- Relative Strength Index (RSI)
- ETON 45.76
- AMBC 56.27
- Support Level
- ETON $13.78
- AMBC $8.13
- Resistance Level
- ETON $15.73
- AMBC $8.87
- Average True Range (ATR)
- ETON 0.75
- AMBC 0.39
- MACD
- ETON -0.01
- AMBC -0.03
- Stochastic Oscillator
- ETON 31.98
- AMBC 60.71
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.